Finley John David 4
4 · PALISADE BIO, INC. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Finley John David
DirectorCEO, CFO
Transactions
- Award
Restricted Stock Units
2025-02-11+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Stock Option (Right to Buy)
2025-02-11+47,000→ 47,000 totalExercise: $1.13Exp: 2035-02-11→ Common Stock (47,000 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date.